Skip to main content

Advertisement

Log in

A Novel PDGFRβ Rearrangement in Systemic Mastocytosis with an Associated Haematologic Neoplasm

  • Correspondence
  • Published:
Indian Journal of Hematology and Blood Transfusion Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Valent P (2015) Diagnosis and management of mastocytosis: an emerging challenge in applied hematology. Hematol Am Soc Hematol Educ Program 2015:98–105

    Article  Google Scholar 

  2. 2016 Revision to the World Health Organization Classification of myeloid neoplasms and acute leukemia. Blood, American Society of Hematology [Internet] [cited 2019 Dec 3]. https://ashpublications.org/blood/article/127/20/2391/35255/The-2016-revision-to-the-World-Health-Organization

  3. Horny H-P, Sotlar K, Sperr WR, Valent P (2004) Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: a histopathological challenge. J Clin Pathol 57(6):604–608

    Article  Google Scholar 

  4. Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST et al (2003) Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 73(1):12–17

    Article  Google Scholar 

  5. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PP, Huh YO et al (2013) Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease (SM-AHNMD): clinical significance and comparison of chomosomal abnormalities in sm and AHNMD components. Am J Hematol 88(3):219–224

    Article  Google Scholar 

  6. Walz C, Metzgeroth G, Haferlach C, Schmitt-Graeff A, Fabarius A, Hagen V et al (2007) Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor beta gene. Haematologica 92(2):163–169

    Article  CAS  Google Scholar 

  7. Lahortiga I, Akin C, Cools J, Wilson TM, Mentens N, Arthur DC et al (2008) Activity of imatinib in systemic mastocytosis with chronic basophilic leukemia and a PRKG2-PDGFRB fusion. Haematologica 93(1):49–56

    Article  CAS  Google Scholar 

  8. Gallagher G, Horsman DE, Tsang P, Forrest DL (2008) Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders. Cancer Genet Cytogenet 181(1):46–51

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Biju George.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Janet, N.B., Manoj Moni, V.T., Meena, J. et al. A Novel PDGFRβ Rearrangement in Systemic Mastocytosis with an Associated Haematologic Neoplasm. Indian J Hematol Blood Transfus 36, 773–775 (2020). https://doi.org/10.1007/s12288-020-01287-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12288-020-01287-8

Navigation